Subconjunctival bevacizumab for corneal neovascularization

被引：0
|
作者：
Mesut Erdurmus
Yuksel Totan
机构：
[1] Fatih University Medical School,Department of Ophthalmology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2007年 / 245卷
关键词：
Bevacizumab; Corneal neovascularization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1577 / 1579
页数：2
相关论文
共 50 条
  • [31] Photodynamic Therapy With Verteporfin Combined With Subconjunctival Injection of Bevacizumab for Corneal Neovascularization
    You, In-Cheon
    Im, Seong-Kyu
    Lee, Seung-Hyun
    Yoon, Kyung-Chul
    CORNEA, 2011, 30 (01) : 30 - 33
  • [32] Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)
    Kim, Tae-im
    Kim, Sang Woo
    Kim, Sunwoong
    Kim, Terry
    Kim, Eung Kweon
    CORNEA, 2008, 27 (03) : 349 - 352
  • [33] Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
    Hashemian, Mohammad Nasser
    Mahrjerdi, Hadi Z.
    Mazloumi, Mehdi
    Safizadeh, Mona S.
    Shakiba, Yadollah
    Rahimi, Firouzeh
    Afarideh, Mohsen
    Zare, Mohamad Ali
    Tafti, Mohammadreza Fallah
    Sepidan, Bahram Bohrani
    Abtahi, Mohammad Ali
    Abtahi, Seyed-Hossein
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2017, 22
  • [34] Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization
    Yin, Xiao-Fang
    Wu, Min-Hui
    Jin, Chen-Jin
    Zhou, Shi-You
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 46
  • [35] Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
    Peng, Wen-yan
    He, Li-wen
    Yin, Xiao-fang
    Zhou, Bin-Bing
    Zhou, Tao
    Zhou, Shi-you
    FRONTIERS IN MEDICINE, 2023, 10
  • [36] Comparison of the inhibitory effect of different doses of subconjunctival bevacizumab application in an experimental model of corneal neovascularization
    Ulas, Burak
    Altan-Yaycioglu, Rana
    Bal, Nebil
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (07) : 1090 - 1095
  • [37] Prevention and Treatment of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Corticosteroid in Experimental Rats
    Hashemian, Mohammad Naser
    Moghimi, Sasan
    Kiumehr, Saman
    Riazi, Mohammad
    Amoli, Fahime Asadi
    OPHTHALMIC RESEARCH, 2009, 42 (02) : 90 - 95
  • [38] Bevacizumab for the Treatment of Corneal Neovascularization
    Chen, Wei-Li
    Chen, Yan-Ming
    Chu, Hsiao-Sang
    Lin, Ying-Han
    Tsai, Tzu-Yun
    Hu, Fung-Rong
    CORNEA, 2009, 28 (09) : S26 - S30
  • [39] The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
    Mello, Glauco Reggiani
    Pizzolatti, Marcos Longo
    Wasilewski, Daniel
    Santhiago, Marcony R.
    Budel, Vinicius
    Moreira, Hamilton
    CLINICS, 2011, 66 (08) : 1443 - 1449
  • [40] Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation
    Dohlman, Thomas H.
    Singh, Rohan Bir
    Amparo, Francisco
    Carreno-Galeano, Tatiana
    Dastjerdi, Mohammad
    Coco, Giulia
    Di Zazzo, Antonio
    Shikan, Hasanain
    Saboo, Ujwala
    Sippel, Kimberly
    Ciralsky, Jessica
    Yoo, Sonia H.
    Sticca, Matheus
    Wakamatsu, Tais H.
    Murthy, Somasheila
    Hamrah, Pedram
    Jurkunas, Ula
    Ciolino, Joseph B.
    Saeed, Hajirah
    Gomes, Jose A. P.
    Perez, Victor L.
    Yin, Jia
    Dana, Reza
    OPHTHALMOLOGY SCIENCE, 2024, 4 (04):
12345